Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance

Experimental and Therapeutic Medicine

Volumn 3, Issue 5, 2012, Pages 845-852

  Tome, Margaret E ^a   Frye, Jennifer B ^a   Coyle, Donna L ^a,b   Jacobson, Elaine L ^a   Samulitis, Betty K ^b   Dvorak, Katerina ^a   Dorr, Robert T ^b   Briehl, Margaret M ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Catalase; Lymphoma; Reactive oxygen species

Indexed keywords

CATALASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUCOCORTICOID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDOREDUCTASE; PARAQUAT; PYRIDINE NUCLEOTIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; VINCRISTINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER RESISTANCE; CELL POPULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; LYMPHOMA CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; THYMUS LYMPHOMA; UPREGULATION;

EID: 84858656653     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.487     Document Type: Article

References (48)

1. Tavani A, La Vecchia C, Franceschi S, Serraino D and Carbone A: Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev 9: 59-64, 2000.
2. Jaffe ES, Harris NL, Stein H and Vardiman JW: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001.
3. Young LS and Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768, 2004.
4. Ramos-Casals M, De Vita S and Tzioufas AG: Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 4: 8-15, 2005.
5. Gualandi G, Giselico L, Carloni M, Palitti F, Mosesso P and Alfonsi AM: Enhancement of genetic instability in human B cells by Epstein-Barr virus latent infection. Mutagenesis 16: 203-208, 2001.
6. Spitz DR, Li GC, McCormick ML, Sun Y and Oberley LW: Stable H2O2-resistant variants of Chinese hamster fibroblasts demonstrate increases in catalase activity. Radiat Res 114: 114-124, 1988.
7. Cantoni O, Guidarelli A, Sestili P, Mannello F, Gazzanelli G and Cattabeni F: Development and characterization of hydrogen peroxide-resistant Chinese hamster ovary cell variants. I. Relationship between catalase activity and the induction/stability of the oxidant-resistant phenotype. Biochem Pharmacol 45: 2251-2257, 1993.
8. Tome ME and Briehl MM: Thymocytes selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis. Cell Death Differ 8: 953-961, 2001.
9. Tome ME, Baker AF, Powis G, Payne CM and Briehl MM: Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res 61: 2766-2773, 2001.
10. Harris AW, Bankhurst AD, Mason S and Warner NL: Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line. J Immunol 110: 431-438, 1973.
11. Carlberg I and Mannervik B: Glutathione reductase. Methods Enzymol 113: 484-490, 1985.
12. Ernster L: DT diaphorase. Methods Enzymol 10: 309-317, 1967.
13. Tome ME, Johnson DBF, Samulitis BK, Dorr RT and Briehl MM: Glucose 6-phosphate dehydrogenase overexpression models glucose deprivation and sensitizes lymphoma cells to apoptosis. Antioxid Redox Signal 8: 1315-1327, 2006.
14. Efferth T, Briehl MM and Tome ME: Role of antioxidant genes for the activity of artesunate against tumor cells. Int J Oncol 23: 1231-1235, 2003.
15. Tome ME, Jaramillo MC and Briehl MM: Hydrogen peroxide signaling is required for glucocorticoid-induced apoptosis in lymphoma cells. Free Radic Biol Med 51: 2048-2059, 2011.
16. Jones DP, Carlson JL, Samiec PS, Sternberg P Jr, Mody VC Jr, Reed RL and Brown LA: Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta 275: 175-184, 1998.
17. Jacobson EL and Jacobson MK: Tissue NAD as a biochemical measure of niacin status in humans. Methods Enzymol 280: 221-230, 1997.
18. Jones DP: Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 348: 93-112, 2002.
19. Li JJ, Oberley LW, St Clair DK, Ridnour LA and Oberley TD: Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 10: 1989-2000, 1995.
20. Moore DS and McCabe GP: Introduction to the Practice of Statistics. 4th edition. W.H. Freeman & Co., New York, 2003.
21. Myers JL and Well AD: Research Design and Statistical Analysis. 2nd edition. Lawrence Erlbaum Associates, Mahwah, NJ, 2003.
22. Schafer FQ and Buettner GR: Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001.
23. Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TJ and Jones DP: Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med 27: 1208-1218, 1999.
24. Kirkman HN and Gaetani GF: Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH. Proc Natl Acad Sci USA 81: 4343-4347, 1984.
25. Go YM, Gipp JJ, Mulcahy RT and Jones DP: H2O2-dependent activation of GCLC-ARE4 reporter occurs by mitogen-activated protein kinase pathways without oxidation of cellular glutathione or thioredoxin-1. J Biol Chem 279: 5837-5845, 2004.
26. Talalay P: Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 12: 5-11, 2000.
27. Hayes JD and Pulford DJ: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995.
28. •- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. J Biol Chem 280: 4254-4263, 2005.
29. Krall J, Bagley AC, Mullenbach GT, Hallewell RA and Lynch RE: Superoxide mediates the toxicity of paraquat for cultured mammalian cells. J Biol Chem 263: 1910-1914, 1988.
30. Esterbauer H, Schaur RJ and Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128, 1991.
31. Jewell SA, Di Monte D, Richelmi P, Bellomo G and Orrenius S: tert-Butylhydroperoxide-induced toxicity in isolated hepatocytes: contribution of thiol oxidation and lipid peroxidation. J Biochem Toxicol 1: 13-22, 1986.
32. Perry MC, Anderson CM, Dorr VJ and Wilkes JD: Companion Handbook to the Chemotherapy Source Book. Lippincott, Williams & Wilkins, New York, 1999.
33. Kamio T, Toki T, Kanezaki R, et al: B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs. Blood 102: 3317-3322, 2003.
34. Matsunaga T, Sakamaki S, Kuga T, et al: GST-pi gene-transduced hematopoietic progenitor cell transplantation overcomes the bone marrow toxicity of cyclophosphamide in mice. Hum Gene Ther 11: 1671-1681, 2000.
35. McGown AT and Fox BW: A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother Pharmacol 17: 223-226, 1986.
36. O'Brien M, Kruh GD and Tew KD: The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J Pharmacol Exp Ther 294: 480-487, 2000.
37. Harbottle A, Daly AK, Atherton K and Campbell FC: Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance. Int J Cancer 92: 777-783, 2001.
38. Depeille P, Cuq P, Mary S, Passagne I, Evrard A, Cupissol D and Vian L: Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects. Mol Pharmacol 65: 897-905, 2004.
39. Tonomura N, McLaughlin K, Grimm L, Goldsby RA and Osborne BA: Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity. J Immunol 170: 2469-2478, 2003.
40. Davies KJ: Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 61: 1-31, 1995.
41. Gewirtz DA: A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727-741, 1999.
42. Trevino AV, Woynarowska BA, Herman TS, Priebe W and Woynarowski JM: Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues. Mol Cancer Ther 3: 1403-1410, 2004.
43. Shacter E, Williams JA, Hinson RM, Senturker S and Lee YJ: Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood 96: 307-313, 2000.
44. Murata M, Suzuki T, Midorikawa K, Oikawa S and Kawanishi S: Oxidative DNA damage induced by a hydroperoxide derivative of cyclophosphamide. Free Radic Biol Med 37: 793-802, 2004.
45. Huang Y, Fang Y, Wu J, Dziadyk JM, Zhu X, Sui M and Fan W: Regulation of Vinca alkaloid-induced apoptosis by NF-kappaB/IkappaB pathway in human tumor cells. Mol Cancer Ther 3: 271-277, 2004.
46. Adler V, Yin Z, Fuchs SY, et al: Regulation of JNK signaling by GSTp. EMBO J 18: 1321-1334, 1999.
47. Townsend DM and Tew KD: The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22: 7369-7375, 2003.
48. Hosono N, Kishi S, Iho S, et al: Glutathione S-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line. Cancer Sci 101: 767-773, 2010.